Characterization of immunomodulatory activity of eIF4A protein
2011
Study of eIF4A Protein as an Immunomodulator
publication
Evidence: moderate
Author Information
Author(s): Barhoumi Mourad, Koutsoni Olga, Guizani Ikram, Dotsika Eleni
Primary Institution: Institut Pasteur de Tunis
Hypothesis
Can eIF4A protein be validated as a natural adjuvant?
Conclusion
eIF4A proteins can activate dendritic cells and induce inflammation, suggesting their potential use in vaccines or immunotherapy.
Supporting Evidence
- eIF4A proteins activated dendritic cells to express co-stimulatory molecules.
- eIF4A proteins induced the production of IL-12p40/p70 and iNOS in vitro.
- Injection of eIF4A proteins caused inflammation similar to the adjuvant Alum.
Takeaway
The eIF4A protein helps the immune system work better, which could be useful for vaccines.
Methodology
The study involved expressing and purifying eIF4A proteins and assessing their effects on dendritic cells in mice.
Want to read the original?
Access the complete publication on the publisher's website